4-methoxyamphetamine has been researched along with lysergic acid diethylamide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Winter, JC | 1 |
| Schulz, R | 1 |
| Kast, E | 1 |
| Hoeh, NR; Jing, X; Menkes, DB | 1 |
1 review(s) available for 4-methoxyamphetamine and lysergic acid diethylamide
| Article | Year |
|---|---|
Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.
Topics: Death; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Terminal Care | 2023 |
3 other study(ies) available for 4-methoxyamphetamine and lysergic acid diethylamide
| Article | Year |
|---|---|
The stimulus properties of para-methoxyamphetamine: a nonessential serotonergic component.
Topics: Amphetamines; Animals; Conditioning, Operant; Dextroamphetamine; Female; Lysergic Acid Diethylamide; Mescaline; Pizotyline; Rats; Rats, Inbred Strains; Serotonin | 1984 |
Meeting the three major needs of the dying patient.
Topics: Cannabis; Death; Environment; Ethanol; Humans; Love; Lysergic Acid Diethylamide; Palliative Care; Physician-Patient Relations; Phytotherapy; Self Concept; Terminal Care | 1976 |
LSD and the dying patient.
Topics: Chlorpromazine; Death; Humans; Lysergic Acid Diethylamide; Neoplasms; Palliative Care | 1966 |